The Brugada Syndrome: a Follow-up Study
- Conditions
- Brugada Syndrome
- Registration Number
- NCT03485508
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Brief Summary
Although for many years the Brugada syndrome has been labelled as a purely electrical disease in the structurally normal heart, the evolution of imaging techniques has enabled the discovery of subtle morphofunctional alterations in some of the Brugada syndrome patients. We will use new echocardiographic techniques to assess cardiac function in these patients and new parameters will be evaluated for their prognostic value as risk stratificators.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- 18 years or older
- Diagnosis of Brugada syndrome
Exclusion Criteria
- history of pericarditis, ischemic heart disease, cardiomyopathy of any origin, structural heart disease, or any other channelopathy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composed outcome of sudden cardiac death, appropriate ICD shock and witnessed ventricular fibrillation 6 years Sudden cardiac death is death occuring within 24 hours after being seen in a healthy status or within 1 hour after initiation of symptoms.
- Secondary Outcome Measures
Name Time Method Syncope 6 years Loss of consciousness
Trial Locations
- Locations (1)
UZ Brussel
🇧🇪Jette, Brussels, Belgium